Tempest Therapeutics
Signal active
Organization
Contact Information
Overview
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor immunity pathways. The company has a balanced and deep pipeline consisting of first-in-class and best-in-class small molecule therapeutics, which modulate distinct pathways relevant to mounting an effective anti-tumor response.
Tempest Therapeutics was established in 2011 and is headquartered in San Francisco, California.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2011
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Tempest Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $3.2B in funding across 36 round(s). With a team of 11-50 employees, Tempest Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - Tempest Therapeutics, raised $15.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
2
Lead Investors
0
Total Funding Amount
$90.0M
Details
2
Tempest Therapeutics has raised a total of $90.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Early Stage Venture | 70.0M | ||
| 2011 | Early Stage Venture | 5.0M |
Investors
Tempest Therapeutics is funded by 16 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Bradley Bolzon | - | FUNDING ROUND - Bradley Bolzon | 15.0M |
| Versant Ventures | - | FUNDING ROUND - Versant Ventures | 15.0M |
| Tempest Therapeutics | - | FUNDING ROUND - Tempest Therapeutics | 15.0M |
| EcoR1 Capital | - | FUNDING ROUND - EcoR1 Capital | 15.0M |
Recent Activity
There is no recent news or activity for this profile.